These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 607511)

  • 1. The effect of somatostatin on epinephrine-induced free fatty acid release in normal man.
    Botha JL; Vinik AI; Child P; Lund A; van Tonder S
    S Afr Med J; 1977 Dec; 52(25):995-7. PubMed ID: 607511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of somatostatin on hormonal and metabolic responses in chronic pancreatitis.
    Botha JL; Vinik AI; le Roith D; Child PT; Jackson WP
    S Afr Med J; 1977 Jun; 51(24):872-5. PubMed ID: 897837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW; Goodner CJ; Koerker DJ; Johnson DG; Ensinck JW
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
    Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
    Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
    Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
    Weiss M; Keller U; Stauffacher W
    Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of metabolic and hormonal responses to somatostatin and propranolol in man.
    Giugliano D; Torella R; Sgambato S
    Acta Diabetol Lat; 1979; 16(1):77-81. PubMed ID: 452822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of insulin and epinephrine in human metabolism: their influence on carbohydrate and lipid oxidation rate.
    Müller-Hess R; Geser CA; Pittet P; Chappuis P; Jéquier E; Felber JP
    Diabete Metab; 1975 Sep; 1(3):151-7. PubMed ID: 1234578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects.
    Scheen A; Cession-Fossion A; Scheen-Lavigne M; Luyckx A
    Horm Metab Res; 1982 May; 14(5):240-5. PubMed ID: 7047346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release.
    Christensen SE; Hansen AP; Iversen J; Lundbaek K; Orskov H; Seyer-Hansen K
    Scand J Clin Lab Invest; 1974 Dec; 34(4):321-5. PubMed ID: 4460228
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of somatostatin on dibutyryl cyclic AMP-induced insulin and growth hormone release in human subjects.
    Peracchi M; Reschini E; Cantalamessa L; Catania A; Giustina G
    Metabolism; 1976 Mar; 25(3):321-8. PubMed ID: 175241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of plasma levels of growth hormone, glucagon and insulin in ducklings: roles of free fatty acids and somatostatin.
    Foltzer C; Strosser MT; Harvey S; Mialhe P
    J Endocrinol; 1985 Jul; 106(1):21-5. PubMed ID: 2862214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retardant effect of hyperglycemia on the rise in plasma fatty acids following insulin withdrawal in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabin D
    Horm Metab Res; 1981 Oct; 13(10):542-5. PubMed ID: 6117512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons.
    Woodson LC; Kempen RR; Bee DE; Potter DE
    Pharmacology; 1978; 17(4):221-6. PubMed ID: 99754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.